Carcinogenesis Advance Access originally published online on March 28, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Carcinogenesis, Vol. 24, No. 9, 1499-1503,
September 2003
© 2003 Oxford University Press
MOLECULAR EPIDEMIOLOGY AND CANCER PREVENTION |
Cyclin D1 gene polymorphism and susceptibility to lung cancer in a Chinese population
1 Institute of Occupational Health and Poison Control, Chinese Center for Disease Control, Beijing 100050, P. R. China
2 Beijing Institute of Tuberculosis and Chest Tumor, Beijing 100090, P. R. China
3 To whom correspondence should be addressed Email: yxzheng{at}163bj.com
The objective was to study the relationship between cyclin D1 gene (CCND1) polymorphism and lung cancer in the Chinese population. Blood samples of 182 cases and 185 controls were collected from a hospital based case-control study. PCR–SSCP was used to examine the G/A polymorphism in exon 4 of CCND1. The results showed that the frequencies of the CCND1 AA, GA and GG genotypes were 31.3, 46.7 and 22.0% respectively in cases, and 21.1, 53.0 and 25.9 respectively in controls. Adjusted by age (in years), sex and smoking status, multivariate logistic regression analysis showed that the AA genotype was associated with a significantly increased risk (OR = 1.87, 95% CI 1.01–3.45) for lung cancer. In the stratification analysis, the CCND1 AA variant genotype was associated with increased risk in individuals who were 
50 years old (OR = 3.23, 95% CI 1.17–8.96) and males (OR = 2.46, 95% CI 1.18–5.10). According to histological types, there was significantly higher frequency of AA genotype in squamous cell lung cancer than that in controls (OR = 2.92, 95% CI 1.07–8.03). In conclusion, it is suggested that the CCND1 G/A polymorphism is associated with the early onset of lung cancer in men and contributes to susceptibility to lung cancer, especially squamous cell cancer, in this population.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  S.S. Han, J.H. No, Y.T. Jeon, J.W. Kim, N.H. Park, Y.S. Song, S.B. Kang, and H.P. Lee Association of cyclin D1 G870A polymorphism with uterine leiomyoma in women whose body mass index values are above 25 kg/m2 Hum. Reprod., March 1, 2008; 23(3): 525 - 529. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Huang, M. R. Spitz, J. Gu, J.J. Lee, J. Lin, S. M.Lippman, and X. Wu Cyclin D1 gene polymorphism as a risk factor for oral premalignant lesions Carcinogenesis, October 1, 2006; 27(10): 2034 - 2037. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. J. Hung, P. Boffetta, F. Canzian, N. Moullan, N. Szeszenia-Dabrowska, D. Zaridze, J. Lissowska, P. Rudnai, E. Fabianova, D. Mates, et al. Sequence Variants in Cell Cycle Control Pathway, X-ray Exposure, and Lung Cancer Risk: A Multicenter Case-Control Study in Central Europe Cancer Res., August 15, 2006; 66(16): 8280 - 8286. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Ceschi, C.-L. Sun, D. Van Den Berg, W.-P. Koh, M. C. Yu, and N. Probst-Hensch The effect of cyclin D1 (CCND1) G870A-polymorphism on breast cancer risk is modified by oxidative stress among Chinese women in Singapore Carcinogenesis, August 1, 2005; 26(8): 1457 - 1464. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.H. Bock, A.S. Wenzlaff, M.L. Cote, S.J. Land, and A.G. Schwartz NQO1 T allele associated with decreased risk of later age at diagnosis lung cancer among never smokers: results from a population-based study Carcinogenesis, February 1, 2005; 26(2): 381 - 386. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. R. Spitz, X. Wu, and G. Mills Integrative Epidemiology: From Risk Assessment to Outcome Prediction J. Clin. Oncol., January 10, 2005; 23(2): 267 - 275. [Abstract] [Full Text] [PDF]
|
|